| C-reactive protein and the type IV collagen measurementin severe COPD: Value of roflumilast M Ostrovskyy, I Savelikhina, K Ostrovska, O Varunkiv, G Korzh, ... European Respiratory Journal 58 (suppl 65), 2021 | 2 | 2021 |
| Epidemiology of sarcoidosis in Western Ukraine M Ostrovskyy, K Ostrovska, K Shvets, I Savelikhina, O Varunkiv, N Korzh European Respiratory Journal 54 (suppl 63), 2019 | 2 | 2019 |
| The impact of overweight on the quality of life of patients with COPD GOLD III N Korzh, M Ostrovskyy, G Korzh, O Varunkiv, I Savelikhina, ... European Respiratory Journal 62 (suppl 67), 2023 | 1 | 2023 |
| Interpreting the significance of collagen-IV level changes in bronchoalveolar fluid in acute COPD exacerbation before and after tiotropium bromide treatment M Kulynych-Miskiv, M Ostrovskyy, V Miskiv, I Savelikhina, O Varunkiv, ... European Respiratory Journal 62 (suppl 67), 2023 | 1 | 2023 |
| The effectiveness of rehabilitation programs depending on the COPD risk group K Shvets, M Ostrovskyy, O Varunkiv, I Savelikhina, M Kulynych-Miskiv, ... European Respiratory Journal 62 (suppl 67), 2023 | 1 | 2023 |
| Effectiveness of roflumilast, a phosphodiesterase type-4 (PDE4) inhibitor on biomarkers of inflammation in COPD I Savelikhina, M Ostrovskyy, A Zuban, O Varunkiv, M Kulynych-Miskiv, ... European Respiratory Journal 62 (suppl 67), 2023 | 1 | 2023 |
| The role of physical rehabilitation in the treatment of COPD K Shvets, M Ostrovskyy, O Varunkiv, I Savelikhina, M Kulynych-Miskiv, ... European Respiratory Journal 60 (suppl 66), 2022 | 1 | 2022 |
| NEW POSSIBILITIES FOR MODIFYING THE COURSE OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE: THE EFFECT OF TIOTROPIUM BROMIDE ON CERTAIN PATHOGENETIC LINKS OF NEOCOLLAGENOGENESIS AND … MM Ostrovskyy, MO Kulynych-Miskiv, KI Volnytska, LD Todoriko, ... Wiadomości Lekarskie 75 (2), 473-477, 2022 | 1 | 2022 |
| Effect of roflumilast on cytokines levels in patients with Chronic Obstructive Pulmonary Disease M Ostrovskyy, I Savelikhina, K Ostrovska, O Varunkiv, M Kulynych-Miskiv, ... European Respiratory Journal 58 (suppl 65), 2021 | 1 | 2021 |
| Comorbidity of sarcoidosis in mountainous regions of Western Ukraine: a based-cohort (n= 592) patients analysis K Shvets, M Ostrovskyy, K Ostrovska, O Varunkiv, M Kulynych-Miskiv, ... European Respiratory Journal 58 (suppl 65), 2021 | 1 | 2021 |
| The diagnostic value of leptin in progression of GOLD III COPD in patients with excessive body weight M Ostrovskyy, N Korzh, K Ostrovska, G Korzh, M Kulynych-Miskiv, ... European Respiratory Journal 58 (suppl 65), 2021 | 1 | 2021 |
| Dynamics of marker of inflammation-sICAM-1 in the process of treatment of COPD GOLD III destabilization phase in overweight patients M Ostrovskyy, N Korzh, G Korzh, K Ostrovska, M Kulynych-Miskiv, ... European Respiratory Journal 58 (suppl 65), 2021 | 1 | 2021 |
| The role of physical rehabilitation in the treatment of bronchial asthma patients M Ostrovskyy, K Shvets, K Ostrovska, I Savelikhina, O Varunkiv, ... European Respiratory Journal 58 (suppl 65), 2021 | 1 | 2021 |
| Predictors of Progression in Patients with Pulmonary Sarcoidosis K Shvets, M Ostrovskyy, I Savelikhina, O Varunkiv, G Korzh, K Ostrovska European Respiratory Journal 56 (suppl 64), 2020 | 1 | 2020 |
| Markers of resistance to corticosteroids therapy in patients with pulmonary sarcoidosis K Shvets, M Ostrovskyy, I Savelikhina, O Varunkiv, G Korzh, K Ostrovska European Respiratory Journal 56 (suppl 64), 2020 | 1 | 2020 |
| The importance of C-reactive protein in patients with acute exacerbation of severe COPD I Savelikhina, K Ostrovska, O Varunkiv, M Ostrovskyy, K Shvets, N Korzh European Respiratory Journal 54 (suppl 63), 2019 | 1 | 2019 |
| Результати лікування та критерії прогресування саркоїдозу органів дихання КВ Швець, ММ Островський ScienceRise. Medical science, 33-38, 2018 | 1 | 2018 |
| Interleukin-2 and C-reactive protein in assessing the effectiveness of pulmonary sarcoidosis treatment M Ostrovskyy, K Shvets, K Ostrovska, I Savelikhina, M Kulynych-Miskiv, ... European Respiratory Journal 50 (suppl 61), 2017 | 1 | 2017 |
| RISK FACTORS FOR GC-RESISTANT PULMONARY SARCOIDOSIS MM Ostrovskyy, KV Shvets, MO Kulynych-Miskiv, IO Savelikhina, ... INDEXED IN PUBMED/MEDLINE, SCOPUS, EMBASE, EBSCO, INDEX COPERNICUS, POLISH …, 2023 | | 2023 |
| Лабораторні маркери ГКС-резистентного саркоїдозу органів дихання ІІ—ІІІ стадії MM Ostrovskyy, KV Shvets, KM Ostrovska, MO Kulinych-Miskiv, ... Туберкульоз, легеневі хвороби, ВІЛ-інфекція, 17-23, 2020 | | 2020 |
